Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Juli House,19, Kodesoh Street , Ikeja,Pmb 21222
Lagos; Lagos; Map
Tel: +234-0819153
Email: @yahoo.com
Website: http://www.juliplc.com.ng

Full name: Juli Plc

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2037183
ISIN: NGJULI000003
Incorporation Date: 1972

Main Activities

Main Activities: Health and Personal Care Stores | Drugs and Druggists' Sundries Merchant Wholesalers

Company Description

JULI PLC is in charge of Marketing of Wholesale and retail of Pharmaceuticals. Juli is reputable for providing service in distribution of pharmaceutical products. The company pioneered the establishment of pharmacy chain stores in Nigeria. It developed a unique marketing strategy that has created tremendous goodwill, which it now enjoys within the pharmaceutical industry. The company was invited by the Federal Military Government in 1976 to provide pharmaceutical, supermarket and various essential needs…

More

Basic Information

Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 1.67
Volume 10
Turnover 17
Index ALL SHARE INDEX
Market Nigerian Stock Exchange
Ticker JULI
Market Cap Market Cap 333,841
52 Week High 1.75
52 Week Low 1.67
Price to Earnings (P/E) -8.38
Earnings per Share (EPS) -0.2
Dividend Yield 0.03 (December 31, 1999)
Bookvalue 160,531
Enterprise Value 417,801
Quote updated on May 02, 2017
Note: data in NGN Thousands.

Key Executives

Chairman
More

Ownership Details

Wema Bank Plc
30%
Other

Key Stats

Select Items to chart them. 2015 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 228,497
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Nigeria

NGN | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2014
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest